Compare NMRA & FFWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NMRA | FFWM |
|---|---|---|
| Founded | 2019 | 1990 |
| Country | United States | United States |
| Employees | N/A | 485 |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 554.0M | 473.3M |
| IPO Year | 2023 | 2014 |
| Metric | NMRA | FFWM |
|---|---|---|
| Price | $1.72 | $5.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $7.50 | $6.17 |
| AVG Volume (30 Days) | 1.2M | ★ 4.3M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.23 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $34,373,000.00 |
| Revenue This Year | N/A | $56.34 |
| Revenue Next Year | N/A | $10.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $4.59 |
| 52 Week High | $3.65 | $6.72 |
| Indicator | NMRA | FFWM |
|---|---|---|
| Relative Strength Index (RSI) | 37.66 | 51.22 |
| Support Level | $1.67 | $5.44 |
| Resistance Level | $1.95 | $5.97 |
| Average True Range (ATR) | 0.13 | 0.19 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 15.38 | 80.63 |
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.